Multi-Target Compound Library

Catalog No. L9510

The pathogenesis of complex diseases often involves the interplay of multiple biological targets and signaling pathways, making it difficult for single-target drugs to achieve optimal therapeutic outcomes. As a result, single-target treatment strategies may have limited efficacy in certain cases. In contrast, multi-target drugs can act on multiple key targets or related pathways simultaneously, producing synergistic effects that significantly enhance therapeutic effectiveness.
This integrated intervention approach not only facilitates more comprehensive regulation of disease-associated biological networks but also helps to reduce the risk of drug resistance caused by mutations in individual targets. Moreover, due to the synergistic interactions between different targets, multi-target drugs can achieve desired therapeutic outcomes at lower dosages, thereby reducing toxicity and improving both safety and tolerability.
Therefore, multi-target drugs offer a more systematic and efficient strategy for the treatment of complex diseases.
TargetMol’s Multi-Target Compound Library contains 5200 compounds that act on two or more distinct targets, providing a valuable resource for the development of multi-target therapeutics.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.